P W Ladenson

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Strategies for thyrotropin use to monitor patients with treated thyroid carcinoma
    P W Ladenson
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Thyroid 9:429-33. 1999
  2. ncbi American Thyroid Association guidelines for detection of thyroid dysfunction
    P W Ladenson
    The Johns Hopkins University School of Medicine, Baltimore, MD 21287 0003, USA
    Arch Intern Med 160:1573-5. 2000
  3. ncbi The impact of age and gender on papillary thyroid cancer survival
    J Jonklaas
    Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 20007, USA
    J Clin Endocrinol Metab 97:E878-87. 2012
  4. ncbi Practical application of recombinant thyrotropin testing in clinical practice
    P W Ladenson
    Division of Endocrinology and Metabolism, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-0003, USA
    Endocr Pract 7:195-201. 2001
  5. ncbi Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer
    P W Ladenson
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287 4904, USA
    Clin Chem 42:183-7. 1996
  6. ncbi Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study
    P W Ladenson
    Department of Endocrinology and Metabolism, John Hopkins University, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287 0003, USA
    J Clin Endocrinol Metab 95:1349-54. 2010

Collaborators

Detail Information

Publications6

  1. ncbi Strategies for thyrotropin use to monitor patients with treated thyroid carcinoma
    P W Ladenson
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Thyroid 9:429-33. 1999
    ..Physicians should consider patients' pretest probability of disease in deciding whether and how often to perform rTSH-stimulated testing after primary treatment for thyroid carcinoma...
  2. ncbi American Thyroid Association guidelines for detection of thyroid dysfunction
    P W Ladenson
    The Johns Hopkins University School of Medicine, Baltimore, MD 21287 0003, USA
    Arch Intern Med 160:1573-5. 2000
    ..To define the optimal approach to identify patients with thyroid dysfunction...
  3. ncbi The impact of age and gender on papillary thyroid cancer survival
    J Jonklaas
    Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 20007, USA
    J Clin Endocrinol Metab 97:E878-87. 2012
    ..Thyroid cancer predominately affects women, carries a worse prognosis in older age, and may have higher mortality in men. Superimposed on these observations is the fact that most women have attained menopause by age 55 yr...
  4. ncbi Practical application of recombinant thyrotropin testing in clinical practice
    P W Ladenson
    Division of Endocrinology and Metabolism, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-0003, USA
    Endocr Pract 7:195-201. 2001
    ..CONCLUSION: Radioiodine scanning and serum thyroglobulin measurement after intramuscular injection of rTSH are valuable new monitoring options in patients with treated thyroid cancer, avoiding the adverse effects of hypothyroidism...
  5. ncbi Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer
    P W Ladenson
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287 4904, USA
    Clin Chem 42:183-7. 1996
    ..Periodic serum Tg measurements and 131I scans are complementary monitoring techniques. Serum calcitonin measurement and screening for ret protooncogene mutations are both valuable for identifying individuals with MTC...
  6. ncbi Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study
    P W Ladenson
    Department of Endocrinology and Metabolism, John Hopkins University, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287 0003, USA
    J Clin Endocrinol Metab 95:1349-54. 2010
    ..However, DITPA's adverse effects at doses used resulted in a high dropout rate and potentially dangerous skeletal actions were observed...